Stock ISHITADR6 ISHITA DRUGS AND INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ishita Drugs and Industries Limited

Equities

ISHITADR6

INE806D01016

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 01:57:28 2024-06-28 EDT 		5-day change 1st Jan Change
66.89 INR +1.73% Intraday chart for Ishita Drugs and Industries Limited +2.03% -7.02%
05-30 Ishita Drugs and Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
02-13 Ishita Drugs and Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 67.13 43.81 32.74 89.71 123.6 147.8
Enterprise Value (EV) 1 26.5 -3.044 -25.24 35.9 38.9 178.3
P/E ratio 27.1 x 12.5 x 5.98 x 10.8 x 15.4 x 25.6 x
Yield - - - - - -
Capitalization / Revenue 1 x 0.48 x 0.22 x 0.64 x 0.88 x 1.22 x
EV / Revenue 0.39 x -0.03 x -0.17 x 0.26 x 0.28 x 1.48 x
EV / EBITDA 6.54 x -0.59 x -3.31 x 3.91 x 3.56 x 23.4 x
EV / FCF 9.2 x -0.65 x -2.59 x -4.78 x 1.32 x -2.01 x
FCF Yield 10.9% -154% -38.6% -20.9% 75.7% -49.8%
Price to Book 1.11 x 0.68 x 0.47 x 1.15 x 1.44 x 1.61 x
Nbr of stocks (in thousands) 2,990 2,990 2,990 2,990 2,990 2,990
Reference price 2 22.45 14.65 10.95 30.00 41.35 49.42
Announcement Date 18-05-29 19-08-31 20-08-31 21-08-31 22-08-31 23-08-29
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 67.17 90.87 148.3 139.5 140.9 120.7
EBITDA 1 4.051 5.16 7.633 9.179 10.91 7.617
EBIT 1 2.691 3.601 5.858 7.718 9.614 6.325
Operating Margin 4.01% 3.96% 3.95% 5.53% 6.82% 5.24%
Earnings before Tax (EBT) 1 3.232 4.629 7.134 10.54 10.43 7.794
Net income 1 2.478 3.516 5.471 8.296 8.05 5.774
Net margin 3.69% 3.87% 3.69% 5.95% 5.71% 4.78%
EPS 2 0.8287 1.176 1.830 2.770 2.690 1.930
Free Cash Flow 1 2.881 4.692 9.751 -7.506 29.45 -88.88
FCF margin 4.29% 5.16% 6.57% -5.38% 20.9% -73.62%
FCF Conversion (EBITDA) 71.11% 90.93% 127.75% - 269.86% -
FCF Conversion (Net income) 116.26% 133.46% 178.22% - 365.8% -
Dividend per Share - - - - - -
Announcement Date 18-05-29 19-08-31 20-08-31 21-08-31 22-08-31 23-08-29
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 30.5
Net Cash position 1 40.6 46.9 58 53.8 84.8 -
Leverage (Debt/EBITDA) - - - - - 4.008 x
Free Cash Flow 1 2.88 4.69 9.75 -7.51 29.4 -88.9
ROE (net income / shareholders' equity) 4.17% 5.64% 8.18% 11.2% 9.82% 6.5%
ROA (Net income/ Total Assets) 2.35% 2.91% 4.13% 5.13% 5.86% 3.49%
Assets 1 105.7 121 132.5 161.8 137.4 165.5
Book Value Per Share 2 20.30 21.40 23.30 26.10 28.70 30.70
Cash Flow per Share 2 2.260 1.090 1.340 5.860 6.640 2.020
Capex 1 3.07 2.68 0.15 0.05 0.19 1.34
Capex / Sales 4.57% 2.95% 0.1% 0.04% 0.13% 1.11%
Announcement Date 18-05-29 19-08-31 20-08-31 21-08-31 22-08-31 23-08-29
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ISHITA DRUGS AND INDUSTRIES LIMITED Stock Ishita Drugs and Industries Limited
-7.02% 2.36M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 819B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 638B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 329B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 225B
NOVARTIS AG Stock Novartis AG
+12.47% 217B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ISHITADR6 Stock
  4. Financials Ishita Drugs and Industries Limited